Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 738 of 1,261
  1. US 9115092

    Substituted quinazoline and pyrido-pyrimidine derivatives

    Asana BioSciences, LLC · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  2. US 9115094

    Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using

    The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  3. US 9107883

    Compounds and methods for treating aberrant adrenocartical cell disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  4. US 9108934

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  5. US 9108903

    Amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  6. US 9110064

    Methods for diagnosis and treatment of endometrial cancer

    The Regents of the University of California · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  7. US 9107956

    Oligomer-protease inhibitor conjugates

    Nektar Therapeutics · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  8. US 9108970

    Fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  9. US 9109014

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Inovio Pharmaceuticals, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  10. US 9109036

    Immunogenic composition comprising alpha-hemolysin oligopeptides

    INTEGRATED BIOTHERAPEUTICS, INC. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  11. US 9108921

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  12. US 9108918

    Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate

    Almirall, S.A. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  13. US 9107957

    Peptide-based in vivo siRNA delivery system

    Arrowhead Madison, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  14. US 9107940

    Compositions and methods for treating and preventing skeletal muscle deficiencies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  15. US 9107938

    Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  16. US 9107912

    Methods for concomitant treatment of theophylline and febuxostat

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  17. US 9107887

    Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

    Provectus Pharmaceuticals, Inc. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  18. US 9107897

    Methods for isolating mammalian retinal progenitor cells

    The Regents of the University of California · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  19. US 9107866

    Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic Escherichia coli

    United States of America as represented by the Secretary of the Air Force · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  20. US 9107832

    Risperidone microparticles formed by sublimation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted
  21. US 9101582

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  22. US 9101565

    Dissolution stability of calcium carbonate tablets

    TAKEDA NYCOMED AS · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  23. US 9103826

    Methods and biomarkers for the detection of dengue hemorrhagic fever

    The Board of Regents of the University of Texas System · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted
  24. US 9102752

    Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

    United Biomedical, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.